Myelin basic protein inhibitor
Selective inhibitor of MLC kinase (Ki=3.8 µM). Inhibits insulin-stimulated 2-deoxyglucose transport and PP-1 activation in adipocytes, possibly via an effect on MAP kinase or its activation. Useful PKB inhibitor (IC50=10-50 µM). Also known to inhibit PKA (IC50=20 µM) and S6 kinase (IC50=50 µM). Does not inhibit PI 3-kinase.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
Alternative Name |
1-(5-Chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine . HCl |
---|---|
Appearance |
White solid. |
CAS |
105637-50-1 |
Couple Target |
Akt, MLCK, PKA, S6 kinase |
Couple Type |
Inhibitor |
Formula |
C15H17N2O2SCl . HCl |
Identity |
Determined by 1H-NMR and MS. |
MW |
361.3 |
Purity |
≥98% (TLC) |
Solubility |
Soluble in DMSO (10mg/ml) and ethanol/water (1:1, 10mg/ml). |
Handling & Storage
Use/Stability |
As indicated on product label or CoA when stored as recommended. Stable for at least 1 year after receipt when stored, as supplied, at 0-4°C. Stock solutions are stable for up to 3 months at -20°C. |
---|---|
Handling |
Protect from light. |
Long Term Storage |
+4°C |
Shipping |
Ambient Temperature |
Regulatory Status |
RUO – Research Use Only |
---|
- Additive effects of low concentrations of estradiol-17β and progesterone on nitric oxide production by human vascular endothelial cells through shared signaling pathways: Y. Pang & P. Thomas; J. Steroid Biochem. Mol. Biol. 165, 258 (2017), Application(s): Involvement of kinase signaling pathways in stimulation of NO production, Abstract
- PKB inhibition prevents the stimulatory effect of insulin on glucose transport and protein translocation but not the antilipolytic effect in rat adipocytes: U. Smith, et al.; Biochem. Biophys. Res. Commun. 268, 315 (2000), Abstract
- Stimulation of protein phosphatase-1 activity by insulin in rat adipocytes. Evaluation of the role of mitogen-activated protein kinase pathway: N. Begum; J. Biol. Chem. 270, 709 (1995), Abstract
- Naphthalenesulfonamide derivatives ML9 and W7 inhibit catecholamine secretion in intact and permeabilized chromaffin cells: J.A. Reig, et al.; Neurochem. Res. 18, 317 (1993), Abstract
- Effects of ML-9 on insulin stimulation of glucose transport in 3T3-L1 adipocytes: G. Inoue, et al.; J. Biol. Chem. 268, 5272 (1993), Abstract
- Effects of HA1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle: M. Seto, et al.; Eur. J. Pharmacol. 195, 267 (1991), Abstract
- Effects of myosin light-chain kinase inhibitor on catecholamine secretion from rat pheochromocytoma PC12h cells: T. Nagatsu, et al.; Biochem. Biophys. Res. Commun. 143, 1045 (1987), Abstract
- Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase: M. Saitoh, et al.; J. Biol. Chem. 262, 7796 (1987), Abstract
- The modulatory role of myosin light chain phosphorylation in human platelet activation: M. Saitoh, et al.; Biochem. Biophys. Res. Commun. 140, 280 (1986), Abstract
Related Products

CAS | 38966-21-1 |
---|---|
Couple Type | Inhibitor |
Purity | ≥98% (TLC) |

Alternative Name | 6-(6-Methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6,8-dihydrofuro[3,4-E][1,3]benzodioxol-8-ol, (+)-Decumbensine |
---|---|
CAS | 6883-44-9 |
Purity | ≥98% (HPLC) |

Alternative Name | (3S,3aR,4R,4aS,8aR,9aS)-4-[(1E)-2-[(2R,6S)-1,6-Dimethyl-2-piperdinyl]ethenyl]decahydro-3-methyl-naphtho[2,3-c]furan-1(3H)-one |
---|---|
CAS | 6879-74-9 |
Couple Type | Inhibitor |
Purity | ≥98% |
Last modified: May 29, 2024
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form